TargetRx is a new drug R&D company with international advanced technology

News

2017-12-05 Views:

TargetRx is a new drug R&D company with international advanced technology. We are committed to challenging the major medical problems of acquired cancer drug resistance, and developing the next-generation small molecule targeted first-in-class drugs with independent intellectual rights for the treatment of cancer. We believe that the new drugs we develop can inhibit cancer and bring hope to patients.

Prev: TargetRx to present PhaseⅠclinical data of TGRX-326 at the 2023 ASCO Annual Meeting

Next: Shenzhen grants 28.4 million yuan of start-up subsidies to overseas returnees, among which the top four are all biopharmaceutical companies